TF
Tiago Fauth Wells Fargo Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
25
Avg Return
Past Year
Past Year
23%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
72.4%
Neutral
27.6%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $217 |
45%
upside
| 5 | +12% |
0
%
| 31 Oct ‘25 4 months ago |
|
|
|
Overweight
Maintained
| $18 |
31%
upside
| 2 | +35% |
0
%
| 4 Sep ‘25 6 months ago |
|
|
|
Equal-Weight
Maintained
| $414 |
16%
downside
| 3 | – |
–
| 3 Sep ‘25 6 months ago |
|
|
|
Overweight
Maintained
| $10 |
239%
upside
| 1 | -49% |
0
%
| 3 Sep ‘25 6 months ago |
|
|
|
Overweight
Maintained
| $73 |
14%
upside
| 4 | +9.6% |
0
%
| 20 Aug ‘25 6 months ago |
|
|
|
Overweight
Maintained
| $31 |
10%
downside
| 3 | +35% |
0
%
| 13 Aug ‘25 6 months ago |
|
|
|
Equal-Weight
Maintained
| $395 |
21%
upside
| 3 | – |
–
| 1 Aug ‘25 7 months ago |
|
|
|
Overweight
Maintained
| $65 |
198%
upside
| 1 | -47% |
0
%
| 10 Jul ‘25 7 months ago |
|
|
|
Equal-Weight
Downgraded
| $107 | – | 3 | +20% |
0
%
| 10 Jul ‘25 7 months ago |
|
|
|
Overweight
Maintained
| $76 |
14%
upside
| 1 | +48% |
0
%
| 30 Jun ‘25 8 months ago |
|
|
|
Overweight
Maintained
| $7 |
25%
upside
| 1 | +190% |
0
%
| 28 May ‘25 9 months ago |
|
|
|
Equal-Weight
Downgraded
| $4 |
0%
upside
| 1 | -29% |
–
| 16 May ‘25 9 months ago |
|
|
|
Overweight
Maintained
| $101 |
268%
upside
| 1 | +24% |
0
%
| 21 Mar ‘25 11 months ago |
|